Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.490
-0.120 (-2.60%)
At close: Mar 13, 2026, 4:00 PM EDT
4.460
-0.030 (-0.67%)
After-hours: Mar 13, 2026, 5:44 PM EDT
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $1.23 billion as of March 13, 2026. Its market cap has increased by 277.32% in one year.
Market Cap
1.23B
Enterprise Value
1.00B
1-Year Change
277.32%
Ranking
Category
Stock Price
$4.49
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $1.23B, an increase of 78.14%. That is a compound annual growth rate of 11.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.23B | -18.36% |
| Dec 31, 2025 | 1.51B | 324.92% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.35B |
| Immatics | 1.34B |
| Bicara Therapeutics | 1.29B |
| MoonLake Immunotherapeutics | 1.28B |
| ORIC Pharmaceuticals | 1.26B |
| DBV Technologies | 1.25B |
| EyePoint | 1.24B |
| Inventiva | 1.23B |